ADR Adherium Ltd
- 0.016
- 0.0000.00%
Adherium Ltd News
JPMorgan Adjusts Stake in Adherium Ltd.
FIL Limited Modifies Stake in Adherium Ltd.
Stocks of the Hour: Adherium, Nanoveu, Nimy Resources
Adherium (ASX:ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial.
Adherium Partners With AstraZeneca for Hailie Smartinhaler Trial
Respiratory eHealth company Adherium (ASX:ADR) entered into an agreement with AstraZeneca to conduct a clinical trial involving its Hailie Smartinhaler platform, according to a Friday filing with the Australian Securities Exchange.
Adherium Raises Nearly AU$7 Million From Entitlement Offer
Digital health company Adherium (ASX:ADR) raised AU$6.8 million from an entitlement offer of up to 340 million shares at AU$0.02 apiece, according to a Thursday filing with the Australian bourse. The
Bank of America Ends Major Stake in Adherium Ltd
Bank of America Acquires Stake in Adherium Ltd
Adherium Ltd. Sees Major Shareholding Shift
Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%
Adherium (ASX:ADR) is seeking to raise about AU$8.4 million for research and product development; sales, marketing and business development; overseas expansion and staffing; customer onboarding and sc
Adherium Ltd.'s Strategic Capital Raise
Adherium Ltd Requests ASX Trading Halt
Adherium's Hailie Smartinhaler Secures FDA Approval for Use With AstraZeneca's Airsupra and Breztri Inhalation Devices
Respiratory eHealth company Adherium's (ASX:ADR) Hailie Smartinhaler obtained clearance from the US Food and Drug Administration for use with AstraZeneca's Airsupra and Breztri inhalation devices, according to a Monday filing with the Australian Securities Exchange.
Adherium Signs Partnership Deal With Rimidi for Asthma Medication
Adherium (ASX:ADR) signed a partnership deal with Rimidi to integrate its asthma medication solution into the latter's clinical management platform, according to a Wednesday filing with the Australian
Adherium's Research Collaboration With US Intermountain, CareCentra Enrolls First Patient
Digital health company Adherium (ASX:ADR) said the first patient has been enrolled in a new research partnership between US Intermountain Health and CareCentra aimed at examining the benefit of e-heal
Adherium Secures AU$1.5 Million R&D Tax Rebate for Fiscal Year 2023
Adherium (ASX:ADR) secured a AU$1.5 million rebate from the Australian government's research and development tax incentive scheme, according to a filing with the Australian Securities Exchange on Thur
Adherium Appoints CEO
Digital health company Adherium (ASX:ADR) appointed Paul Mastoridis as chief executive, effective Thursday, following the resignation of Rick Legleiter. Mastoridis has more than 25 years' experience i
Adherium and NuvoAir Medical Forge Partnership for Improved Patient Outcomes
Adherium (ASX:ADR) entered an agreement with NuvoAir Medical, under which NuvoAir will purchase a minimum of 1,000 next-generation Hailie Smartinhaler sensors, the digital health company said Wednesda
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%
Adherium (ASX:ADR) delivered the first purchase order agreement for 1,750 next-generation Hailie Smartinhaler sensors to the US hospital system Intermountain Health, the digital health company said Mo
Adherium Completes 1-for-15 Share Consolidation
Adherium (ASX:ADR) completed its 1-for-15 share consolidation following shareholder approval of the move at a Nov. 30 annual general meeting. Following consolidation, the respiratory eHealth company's
Adherium Confirms Enrolment of First Patients at SENTA Partners
Adherium (ASX:ADR) confirmed the enrolment of the first patients and the start of remote patient monitoring as part of THR commercial rollout of the Hailie platform. The first patients are being monit
Analysis
Price Target
No Data
